Drug intelligence / Profile preview

Suxiao Jiuxin Pills

Development stage
Phase 4
Lead developer
Tianjin Pharmaceutical Da Ren Tang Group
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral, Sublingual
01

Overview

Suxiao Jiuxin Pills is a traditional Chinese medicine formulation widely used in China for the treatment of cardiovascular diseases such as angina pectoris and coronary heart disease. Developed in the 1980s by Chenggui Zhang, it is composed primarily of two herbal ingredients: Ligusticum chuanxiong Hort. (Chuanxiong) and Borneolum syntheticum (Borneol). The main active constituents include phthalides (such as senkyunolide A), phenolic acids (ferulic acid), alkaloids (ligustrazine/tetramethylpyrazine), and borneol. Mechanistically, these compounds exert vasodilatory effects by relaxing vascular smooth muscle—likely through modulation of calcium channels and potassium channels—and improving myocardial blood supply. The pill has demonstrated efficacy in relieving angina symptoms rapidly without significant side effects and may also improve microcirculation, reduce inflammation, support endothelial function, inhibit arrhythmias via potassium channel blockade (notably hKv1.5), and provide cardioprotective effects against ischemia-reperfusion injury[1][2][3][6][7]. It is included on China's national essential drug list for cardiocerebral vascular diseases.

Brand names
Suxiao Jiuxin PillsSuxiao Jiuxin Wan
Other names
SJPSXJSuxiao Jiuxin Wan
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)NOS3 (eNOS)KCNA5 (Ultra-rapid delayed rectifier potassium channel)

Beyond the preview

Go deeper on Suxiao Jiuxin Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suxiao Jiuxin Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call